What Does the Future Hold for Hydroxamates in Cancer Therapy?
The future of hydroxamates in cancer therapy looks promising, with ongoing research focused on improving their selectivity, reducing side effects, and enhancing their efficacy through combination therapies. Advances in personalized medicine and the identification of biomarkers for HDAC inhibitor sensitivity may also help tailor treatments to individual patients, maximizing therapeutic benefits while minimizing risks.
